SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-18-014875
Filing Date
2018-03-26
Accepted
2018-03-26 06:07:23
Documents
6
Period of Report
2018-04-16
Effectiveness Date
2018-03-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A s002111x5_def14a.htm DEF 14A 2488653
2 logo_akcea.jpg GRAPHIC 16287
3 s002111x5_address.jpg GRAPHIC 82411
4 s002111x5_cowen.jpg GRAPHIC 12773
5 s002111x5_proxy1.jpg GRAPHIC 1492797
6 s002111x5_proxy2.jpg GRAPHIC 820439
  Complete submission text file 0001140361-18-014875.txt   5613007
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38137 | Film No.: 18711540
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1